Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
Clinical trial NCT04103060 · COMPLETED
Trial details
- NCT number
- NCT04103060
- Sponsor
- Dermavant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-27
- Primary completion
- 2020-11-03
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.